Home
Conditions
Sphingolipidoses

Clinical trial condition

Sphingolipidoses

Explore clinical trials studying Sphingolipidoses. Study availability and eligibility vary by location and protocol.

389 public trials 81 recruiting studies

Refine in advanced search Browse all conditions

Sphingolipidoses trial results

Active, Not Recruiting

Diagnostic Creteria of Acid Sphingomyelinase Deficiency (ASMD)

NCT07274826

Conditions: Acid Sphingomyelinase Deficiency (ASMD), Brain Diseases, Brain Diseases, Metabolic, +19 more
Locations: Sohag University Hospital Sohag, Egypt

View Trial Details

Active, Not Recruiting

Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)

NCT06545136

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations: Lysosomal Rare Disorders Research and Treatment Center Fairfax, Virginia, United States

Hospital de Clinicas de Porto Alegre (HCPA) Porto Alegre, Brazil

Hospital Quironsalud Zaragoza Zaragoza, Spain

Salford Royal Hospital Salford, United Kingdom

View Trial Details

Active, Not Recruiting

Long-Term Follow-Up of Subjects Treated With AXO-AAV-GM2 for Tay-Sachs or Sandhoff Disease

NCT06614569

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: UMass Chan Medical School Worcester, Massachusetts, United States

View Trial Details

Active, Not Recruiting

OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)

NCT04283227

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR-TIGET) Milan, Italy

View Trial Details

Active, Not Recruiting

Long Term Follow-Up for Safety of AVR-RD-02

NCT06488261

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

View Trial Details

Active, Not Recruiting

Omics Gaucher Study: Multiomic Approach

NCT05526664

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: UKE Hamburg, Germany

View Trial Details

Active, Not Recruiting

Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores.

NCT07011329

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +38 more
Locations: Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Active, Not Recruiting

Arrhythmia Burden, Risk of Sudden Cardiac Death and Stroke in Patients With Fabry Disease

NCT03305250

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: University of Sydney Sydney, Australia

University Hospitals Birmingham NHS Foundation Trust Birmingham, West Midlands, United Kingdom

Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom

Cardiff and Vale University Health Board Cardiff, United Kingdom

View Trial Details

Active, Not Recruiting

First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis

NCT04798235

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +18 more
Locations: Queen's University/Kingston Health Sciences Centre Kingston, Ontario, Canada

View Trial Details

Sphingolipidoses

Sphingolipidoses trial results

Related conditions